CerielloA. Postprandial hyperglycemia and diabetes complications: Is it time to treat? Diabetes, 2005; 54(1):1–7; doi: 10.2337/diabetes.54.1.1
2.
El-OstaA, BrasacchioD, YaoD, et al.Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. J Exp Med, 2008; 205(10):2409–2417; doi: 10.1084/jem.20081188
3.
YunleiD, QiulingF, XuW, et al.Transient high-glucose stimulation induces persistent inflammatory factor secretion from rat glomerular mesangial cells via an epigenetic mechanism. Cell Physiol Biochem, 2018; 49(5):1747–1754; doi: 10.1159/000493619
4.
Anonymous. Cellular Death, Reactive Oxygen Species (ROS) and Diabetic Complications | Cell Death & Disease. n.d. Available from: https://www.nature.com/articles/s41419-017-0135-z [Last accessed: March15, 2025].
5.
Del PratoS, MarchettiP, BonadonnaRC. Phasic insulin release and metabolic regulation in type 2 diabetes. Diabetes, 2002; 51(Suppl 1):S109–S116; doi: 10.2337/diabetes.51.2007.s109
6.
MendezCE, MokK-T, AtaA, et al.Increased glycemic variability is independently associated with length of stay and mortality in noncritically ill hospitalized patients. Diabetes Care, 2013; 36(12):4091–4097; doi: 10.2337/dc12-2430
7.
AlexanianSM, CheneyMC, Bello RamosJC, et al.Impact of meal insulin bolus timing and bedtime snacking on continuous glucose monitoring-derived glycemic metrics in hospitalized inpatients. Diabetes Technol Ther, 2025; doi: 10.1089/dia.2025.0027
8.
SmithWD, WintersteinAG, JohnsT, et al.Causes of hyperglycemia and hypoglycemia in adult inpatients. Am J Health Syst Pharm, 2005; 62(7):714–719; doi: 10.1093/ajhp/62.7.714
9.
MaynardGA, HuynhMP, RenvallM. Iatrogenic inpatient hypoglycemia: Risk factors, treatment, and prevention: Analysis of current practice at an academic medical center with implications for improvement efforts. Diabetes Spectrum, 2008; 21(4):241–247; doi: 10.2337/diaspect.21.4.241
10.
GeorgeM, ZilbermintM, SokolinskyS, et al.Effects of preprandial versus postprandial nutritional insulin administration in the inpatient setting. Diabetes Res Clin Pract, 2024; 214:111785; doi: 10.1016/j.diabres.2024.111785
11.
HirschIB, DrazninB, BuseJB, et al.; TIGHT RCT Study Group. Results from a randomized trial of intensive glucose management using CGM versus usual care in hospitalized adults with type 2 diabetes: The TIGHT study. Diabetes Care, 2025; 48(1):118–124; doi: 10.2337/dc24-1779
12.
RassamAG, ZeiseTM, BurgeMR, et al.Optimal administration of lispro insulin in hyperglycemic type 1 diabetes. Diabetes Care, 1999; 22(1):133–136; doi: 10.2337/diacare.22.1.133
13.
CobryE, McFannK, MesserL, et al.Timing of meal insulin boluses to achieve optimal postprandial glycemic control in patients with type 1 diabetes. Diabetes Technol Ther, 2010; 12(3):173–177; doi: 10.1089/dia.2009.0112
14.
BrunnerGA, HirschbergerS, SendlhoferG, et al.Post-prandial administration of the insulin analogue insulin aspart in patients with type 1 diabetes mellitus. Diabet Med, 2000; 17(5):371–375; doi: 10.1046/j.1464-5491.2000.00289.x
15.
RatnerR, WynneA, NakhleS, et al.Influence of preprandial vs. postprandial insulin glulisine on weight and glycaemic control in patients initiating basal-bolus regimen for type 2 diabetes: A multicenter, randomized, parallel, open-label study (NCT00135096). Diabetes Obes Metab, 2011; 13(12):1142–1148; doi: 10.1111/j.1463-1326.2011.01478.x
16.
KlaffL, CaoD, DellvaMA, et al.Ultra rapid lispro improves postprandial glucose control compared with lispro in patients with type 1 diabetes: Results from the 26-week PRONTO-T1D study. Diabetes Obes Metab, 2020; 22(10):1799–1807; doi: 10.1111/dom.14100
17.
HirschIB, BeckRW, MarakMC, et al.; INHALE-3 Study Group. A randomized comparison of postprandial glucose excursion using inhaled insulin versus rapid-acting analog insulin in adults with type 1 diabetes using multiple daily injections of insulin or automated insulin delivery. Diabetes Care, 2024; 47(9):1682–1687; doi: 10.2337/dc24-0838
18.
HirschIB, BeckRW, MarakMC, et al.; INHALE-3 Study Group. A randomized trial comparing inhaled insulin plus basal insulin versus usual care in adults with type 1 diabetes. Diabetes Care, 2025; 48(3):353–360; doi: 10.2337/dc24-1832
